Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / CREATE Medicines

CREATE Medicines

Series BUS
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$122Msum of rounds with a disclosed amount only
Named investors
2
Financing history
1 rounds
  1. May 14, 2026
    Series B · $122M (disclosed)
    Arch Venture Partners (participant)Newpath Management, L.P. (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “CREATE Medicines Announces $122 Million Series B Financing to Advance In Vivo CAR Pipeline in Autoimmune Disease and Oncology”
Investors on record
2 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. May 14, 2026
    CREATE Medicines announced Series B of $122,000,000
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company